J&J receives $4.15 billion offer for Ortho-Clinical Diagnostics business from Carlyle Group

CP26841052
In this 2006 photo, a technician at Ortho-Clinical Diagnostics Inc., works in a "sterile filling" room at the plant in Raritan, N.J. THE CANADIAN PRESS/AP, files

NEW BRUNSWICK, N.J. – Johnson & Johnson is being offered $4.15 billion by The Carlyle Group for its Ortho-Clinical Diagnostics business.

The New Brunswick, N.J., company has until the end of March to decide whether to accept the offer. Johnson & Johnson executives will discuss the offer Tuesday, when the health giant and consumer products company reports fourth-quarter results. The company said Thursday that it will consult with works councils and trade unions representing that unit’s employees before making a decision.

The Ortho-Clinical business makes equipment for screening blood supplies and detecting and diagnosing conditions such as HIV, diabetes and high cholesterol. The company said a year ago that it was exploring alternatives such as a sale or spinoff for that business.

Company shares are up 25 cents, to $95.05, in premarket trading.

News from © The Associated Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.

Join the Conversation!

Want to share your thoughts, add context, or connect with others in your community?

Create a free account

The Associated Press

The Associated Press is an independent global news organization dedicated to factual reporting. Founded in 1846, AP today remains the most trusted source of fast, accurate, unbiased news in all formats and the essential provider of the technology and services vital to the news business. More than half the world’s population sees AP journalism every day.

Related Articles